- Home
- QNCX vs TCBS Comparison
QNCX vs TCBS Comparison
Compare QNCX & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- TCBS
- Stock Information
- Founded
- QNCX 2012
- TCBS 1934
- Country
- QNCX United States
- TCBS United States
- Employees
- QNCX N/A
- TCBS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- TCBS Banks
- Sector
- QNCX Health Care
- TCBS Finance
- Exchange
- QNCX Nasdaq
- TCBS Nasdaq
- Market Cap
- QNCX 44.0M
- TCBS 44.9M
- IPO Year
- QNCX 2019
- TCBS N/A
- Fundamental
- Price
- QNCX $1.03
- TCBS $15.37
- Analyst Decision
- QNCX Strong Buy
- TCBS
- Analyst Count
- QNCX 5
- TCBS 0
- Target Price
- QNCX $8.00
- TCBS N/A
- AVG Volume (30 Days)
- QNCX 511.8K
- TCBS 1.9K
- Earning Date
- QNCX 05-16-2025
- TCBS 05-13-2025
- Dividend Yield
- QNCX N/A
- TCBS 1.04%
- EPS Growth
- QNCX N/A
- TCBS N/A
- EPS
- QNCX N/A
- TCBS 0.70
- Revenue
- QNCX N/A
- TCBS $14,488,000.00
- Revenue This Year
- QNCX N/A
- TCBS N/A
- Revenue Next Year
- QNCX N/A
- TCBS N/A
- P/E Ratio
- QNCX N/A
- TCBS $22.01
- Revenue Growth
- QNCX N/A
- TCBS 54.08
- 52 Week Low
- QNCX $0.51
- TCBS $13.51
- 52 Week High
- QNCX $2.45
- TCBS $17.50
- Technical
- Relative Strength Index (RSI)
- QNCX 38.67
- TCBS 44.65
- Support Level
- QNCX $0.98
- TCBS $15.25
- Resistance Level
- QNCX $1.16
- TCBS $15.88
- Average True Range (ATR)
- QNCX 0.09
- TCBS 0.08
- MACD
- QNCX 0.01
- TCBS 0.02
- Stochastic Oscillator
- QNCX 22.22
- TCBS 41.38
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.